Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.

[1]  Qijian Yi,et al.  Serum Levels of Syndecan-1 in Patients With Kawasaki Disease , 2018, The Pediatric infectious disease journal.

[2]  M. Hiki,et al.  Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis. , 2018, Thrombosis research.

[3]  K. Waki,et al.  Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events , 2018, JAMA pediatrics.

[4]  Y. Kawano,et al.  Disruption of Endothelial Cell Homeostasis Plays a Key Role in the Early Pathogenesis of Coronary Artery Abnormalities in Kawasaki Disease , 2017, Scientific Reports.

[5]  W. Tang,et al.  Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications , 2017, Current Heart Failure Reports.

[6]  Hyung-Bok Park,et al.  OPTIMAL CUTOFF VALUE OF ANNUAL CORONARY ARTERY CALCIUM SCORE PROGRESSION BY SERIAL CORONARY CALCIUM SCAN PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ASYMPTOMATIC KOREAN POPULATION , 2016 .

[7]  A. Schmidt,et al.  Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome. , 2016, Atherosclerosis.

[8]  J. Newburger,et al.  Kawasaki Disease. , 2013, Journal of the American College of Cardiology.

[9]  Y. Kawano,et al.  Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[10]  D. Chappell,et al.  Acute degradation of the endothelial glycocalyx in infants undergoing cardiac surgical procedures. , 2015, The Annals of thoracic surgery.

[11]  E. Wu,et al.  Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy , 2015, Archives of Disease in Childhood.

[12]  N. Dahdah,et al.  Value of amino‐terminal pro B‐natriuretic peptide in diagnosing Kawasaki disease , 2012, Pediatrics international : official journal of the Japan Pediatric Society.

[13]  S. Grundmann,et al.  Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. , 2012, Resuscitation.

[14]  T. Shimo,et al.  Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide , 2011, Pediatric Cardiology.

[15]  Hans Vink,et al.  Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease , 2009, Current opinion in lipidology.

[16]  Dick W. Slaaf,et al.  The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.

[17]  T. Ichiyama,et al.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease , 2005, Clinical and experimental immunology.

[18]  Kei Takahashi,et al.  Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[19]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[20]  B. Chiang,et al.  Cytokines predict coronary aneurysm formation in Kawasaki disease patients , 1993, European Journal of Pediatrics.

[21]  Walter R Wilson,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Pediatrics.

[22]  J. Burns,et al.  Kawasaki syndrome , 2004, The Lancet.

[23]  R. Uehara,et al.  Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[24]  T. Hara,et al.  Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease , 2002, European Journal of Pediatrics.

[25]  J. Burns,et al.  Kawasaki Disease: A Brief History , 2000, Pediatrics.

[26]  H. Yanagawa,et al.  Serum C‐reactive protein levels in patients with Kawasaki disease: from the results of nation‐wide surveys of Kawasaki disease in Japan , 1997, Acta paediatrica.

[27]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.